Persones / Equip Humà

Francesc Villarroya Gombau

Buscador de publicacions

Publicacions

  • Moure R, Domingo P, Villarroya-Terrade J, Gasa L, Gallego-Escuredo JM, Quesada T, Morón-Ros S, Maroto AF, Mateo GM, Domingo JC, Villarroya-Gombau F and Giralt M.

    Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/ß-Klotho System.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 62(6): . Nº de cites: 10

    [doi:10.1128/AAC.00029-18]

  • Rupérez CH, Lerin C, Ferrer-Curriu G, Cairo M, Mas-Stachurska A, Sitges M, Villarroya-Terrade J, Giralt M, Villarroya-Gombau F and Planavila A.

    Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 260: 163-170. Nº de cites: 34

    [doi:10.1016/j.ijcard.2018.02.109]

  • Gavaldà-Navarro A, Pastor JJ, Mereu A, Villarroya-Gombau F and Ipharraguerre IR.

    Developmental regulation of the intestinal FGF19 system in domestic pigs.

    AM J PHYSIOL-GASTR L . 314(6): . Nº de cites: 10

    [doi:10.1152/ajpgi.00312.2017]

  • Domingo P, Gallego-Escuredo JM, Fernández I, Villarroya-Terrade J, Torres F, Del Mar Gutierrez M, Mateo MG, Villarroya-Gombau F, Vidal F, Giralt M and Domingo JC.

    Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled study.

    Cytokine . 105: 73-79. Nº de cites: 14

    [doi:10.1016/j.cyto.2018.02.008]

  • Pellitero S, Piquer-Garcia I, Ferrer-Curriu G, Puig R, Martínez E, Moreno P, Tarascó J, Balibrea J, Lerin C, Puig-Domingo M, Villarroya-Gombau F, Planavila A and Sánchez-Infantes D.

    Opposite changes in meteorin-like and oncostatin m levels are associated with metabolic improvements after bariatric surgery.

    INTERNATIONAL JOURNAL OF OBESITY . 42(4): 919-922. Nº de cites: 34

    [doi:10.1038/ijo.2017.268]

  • Zarei M, Barroso E, Palomer FX, Dai J, Rada P, Quesada T, Escolà-Gil JC, Cedó L, Zali MR, Molaei M, Dabiri R, Vázquez S, Pujol E, Valverde ÁM, Villarroya-Gombau F, Liu Y, Wahli W and Vazquez M.

    Hepatic regulation of VLDL receptor by PPARß/d and FGF21 modulates non-alcoholic fatty liver disease.

    molecular metabolism . 8: 117-131. Nº de cites: 74

    [doi:10.1016/j.molmet.2017.12.008]

  • Sánchez-Infantes D, Cereijo R, Sebastiani G, Pérez-Cruz M, Villarroya-Gombau F and Ibañez-Toda L.

    Nerve Growth Factor Levels in Term Human Infants: Relationship to Prenatal Growth and Early Postnatal Feeding

    International Journal of Endocrinology . 2018: 7562702-7562702. Nº de cites: 8

    [doi:10.1155/2018/7562702]

  • Malpique R, Bassols J, López-Bermejo A, Díaz-Silva M, Villarroya-Gombau F, Pavia J, Congo A, de Zegher F and Ibañez-Toda L.

    Liver volume and hepatic adiposity in childhood: relations to body growth and visceral fat

    INTERNATIONAL JOURNAL OF OBESITY . 42(1): 65-71. Nº de cites: 10

    [doi:10.1038/ijo.2017.198]

  • Díaz-Silva M, Gallego-Escuredo JM, López-Bermejo A, de Zegher F, Villarroya-Gombau F and Ibañez-Toda L.

    Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome

    International Journal of Endocrinology . 2018: 4192940-4192940. Nº de cites: 10

    [doi:10.1155/2018/4192940]

  • Villarroya-Gombau F, Gavaldà-Navarro A, Peyrou M, Villarroya-Terrade J and Giralt M.

    The Lives and Times of Brown Adipokines.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 28(12): 855-867. Nº de cites: 69

    [doi:10.1016/j.tem.2017.10.005]